• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Windtree Therapeutics Inc (NQ: WINT )

    2.800 -0.270 (-8.79%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Windtree Therapeutics Inc

    < Previous 1 2 3 4 5 6 7 Next >
    What's Going On With Windtree Therapeutics Stock Wednesday?
    Windtree Therapeutics shares are trading higher Wednesday after the company completed enrollment of its SEISMiC Extension Phase 2b study of istaroxime. 
    Via Benzinga
    Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    WINT Stock Earnings: Windtree Therapeutics Reported Results for Q1 2024
    Windtree Therapeutics just reported results for the first quarter of 2024. 
    Via InvestorPlace
    (WINT) - Analyzing Windtree Therapeutics's Short Interest
    Via Benzinga
    Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?
    Windtree Therapeutics stock is up on Friday with heavy trading of WINT shares following an update on its clinical trials. 
    Via InvestorPlace
    (WINT) - Analyzing Windtree Therapeutics's Short Interest
    Via Benzinga
    Why Windtree Therapeutics (WINT) Stock Is Volatile Today
    Windtree Therapeutics shares are trading lower by 8.6% during Monday's session. The company announced it entered a $1M private placement. 
    Via Benzinga
    S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
    Via Benzinga
    Exposures Fossil Fuels
    Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5%
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    What's Going On With Windtree Therapeutics Stock?
    Windtree Therapeutics shares are racing higher Friday after the company requested the withdrawal of its Registration Statement previously filed with the SEC. 
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Why Is DexCom (DXCM) Stock Down 38% Today?
    DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance. 
    Via InvestorPlace
    Why Is BurgerFi International (BFI) Stock Up 71% Today?
    BurgerFi International stock is up on Friday as investors in BFI react to it reaching a settlement agreement with Lion Point Capital, LP. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday! 
    Via InvestorPlace
    Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news! 
    Via InvestorPlace
    Why Windtree Therapeutics (WINT) Stock Is Getting Hammered
    Windtree Therapeutics shares are trading lower by 30% during Thursday's session. The company announced it approved a 1-for-18 reverse stock split of its common stock. 
    Via Benzinga
    Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    WINT Stock Earnings: Windtree Therapeutics Beats EPS for Q4 2023
    WINT stock results show that Windtree Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate
    Craig Fraser, CEO of Windtree Therapeutics, Inc. (NASDAQ: WINT), was recently interviewed by Benzinga. Windtree is advancing late-stage interventions for cardiovascular disorders to treat patients in... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
    Windtree Therapeutics (NASDAQ: WINT) announced an agreement with affiliates of biopharma investor Deerfield Management Company to fully retire a $15 million contingent liability associated with... 
    Via Benzinga
    Week in Review: Lee’s Pharma Signs $138 Million Agreement For China Rights To Heart Failure Therapy
    Lee’s Pharma acquired China rights to a heart failure therapy from Windtree Therapeutics. Meanwhile, AstraZeneca signed an investment cooperation agreement with the Taizhou National Medical High-tech... 
    Via Talk Markets
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
    Greater China holds a significant, if not the world’s largest, acute heart failure patient population. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.